Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 36.76% | -68.59% | -18.38% | -126.01% | 80.02% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -25.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.24% | 91.81% | 122.22% | 229.36% | -118.60% |
| Change in Net Operating Assets | 154.08% | 551.75% | -92.30% | 205.59% | 185.27% |
| Cash from Operations | 94.17% | -1.91% | -728.11% | 134.50% | 82.19% |
| Capital Expenditure | -43.57% | -0.36% | -14.81% | 40.88% | -24.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43.57% | -0.36% | -14.81% | 40.88% | -24.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,497.22% | 85.77% | -254.27% | -- | -- |
| Cash from Financing | 708.96% | -101.92% | 12,350.00% | -77.24% | 539.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.74% | -194.19% | 184,200.00% | 100.11% | 76.43% |
